PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of boeaboutauthor infoeditorial boardsearchOptics InfoBaseboeThis article
 
Biomed Opt Express. 2011 August 1; 2(8): 2126–2143.
Published online 2011 July 1. doi:  10.1364/BOE.2.002126
PMCID: PMC3149514
Hypochromicity in red blood cells: an experimental and theoretical investigation
Akihisa Nonoyama,1 Alicia Garcia-Lopez,2 Luis H. Garcia-Rubio,3,4* German F. Leparc,4 and Robert L. Potter1
1University of South Florida, Department of Chemistry,4202 E. Fowler Ave, Tampa, Florida 33620-5250, USA
2Los Alamos National Laboratory, New Mexico 8754, USA
3Claro Scientific, St. Petersburg, Florida 33716-3806, USA
4Florida Blood Services, St. Petersburg, Florida 33716, USA
*garlop01/at/gmail.com
Received May 26, 2011; Revised June 30, 2011; Accepted June 30, 2011.
Abstract
Multiwavelength UV-visible transmission spectrophotometry is a useful tool for the examination of micron-size particle suspensions in the context of particle size and chemical composition. This paper reports the reliability of this method to characterize the spectra of purified red blood cells both in their physiological state and with modified hemoglobin content. Previous studies have suggested the contribution of hypochromism on the particle spectra caused by the close electronic interaction of the encapsulated chromophores. Our research shows, however, that this perceived hypochromism can be accounted for by considering two important issues: the acceptance angle of the instrument and the combined scattering and absorption effect of light on the particles. In order to establish these ideas, spectral analysis was performed on purified and modified red cells where the latter was accomplished with a modified hypotonic shock protocol that altered the hemoglobin concentration within the cells. Moreover, the Mie theory was used to successfully simulate the spectral features and trends of the red cells. With this combination of experimental and theoretical exploration, definition of hypochromism has been extended to two subcategories.
OCIS codes: (170.0170) Medical optics and biotechnology, (170.1470) Blood or tissue constituent monitoring
Articles from Biomedical Optics Express are provided here courtesy of
Optical Society of America